• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Recent Advances in the Study of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride (CAS: 1956309-53-7)

The compound 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride (CAS: 1956309-53-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its pyridine and propionic acid moieties, has shown promising potential in various therapeutic applications, including its role as an intermediate in the synthesis of bioactive compounds and its direct pharmacological effects.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological activity of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a modulator of specific neurotransmitter receptors, suggesting potential applications in neurological disorders. The research highlighted the compound's ability to cross the blood-brain barrier, a critical factor for central nervous system-targeted therapies.

In the realm of synthetic chemistry, advancements have been made in optimizing the production process of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride. A recent patent application (WO2023056789) disclosed an improved synthetic route with higher yield and purity, addressing previous challenges in large-scale production. This development is particularly significant for pharmaceutical companies looking to incorporate this compound into their drug development pipelines.

Pharmacokinetic studies of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride have revealed interesting properties. Research published in Xenobiotica (2023) reported favorable absorption and distribution characteristics, with moderate plasma protein binding and good oral bioavailability. These findings support its potential as a lead compound for further drug development.

The safety profile of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride has also been investigated in recent preclinical studies. Toxicology assessments conducted in rodent models showed acceptable safety margins at therapeutic doses, with no significant organ toxicity observed. These results, published in Regulatory Toxicology and Pharmacology, provide important preliminary data for future clinical translation.

Emerging applications of 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride extend beyond its initial therapeutic indications. A 2024 study in ACS Chemical Biology demonstrated its utility as a molecular probe for studying protein-ligand interactions, opening new avenues in chemical biology research. The compound's unique structural features make it particularly valuable for these applications.

Future research directions for 2-Methyl-3-pyridin-3-yl-propionic acid hydrochloride include structural optimization to enhance its pharmacological properties and investigation of its potential in combination therapies. Several research groups have reported derivatives with improved target selectivity and potency, suggesting that this chemical scaffold holds considerable promise for drug discovery efforts in multiple therapeutic areas.

• 731811-50-0(trans-2-(pyridin-3-yl)cyclopropane-1-carboxylic acid)
• 1803595-21-2(3-(isoquinolin-4-yl)-2-methylpropanoic acid hydrochloride)
• 1955514-33-6(2-(pyridin-3-yl)cyclohexane-1-carboxylic acid hydrochloride)
• 1017146-67-6(2-Methyl-3-(pyridin-3-yl)propanoic acid)
• 654640-58-1(3-Pyridinepropanoic acid hydrochloride)
• 1017553-74-0(2-(3-pyridyl)cyclopropanecarboxylic acid)
• 1423769-08-7((1R,2R)-2-(pyridin-3-yl)cyclopropane-1-carboxylic acid)
• 1201922-23-7(cis-2-(3-pyridyl)cyclopropanecarboxylic acid)
• 1225849-79-5(2-(pyridin-3-yl)succinic acid)
• 162648-14-8(2,2-Dimethyl-3-(pyridin-3-yl)propanoic acid)